MARKET

ARNI

ARNI

Arno Therapeutics Inc
EXMKT
0.0001
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
4.93K
P/E (TTM)
-0.0002
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARNI last week (0908-0912)?
Weekly Report · 09/15 10:15
Weekly Report: what happened at ARNI last week (0901-0905)?
Weekly Report · 09/08 10:17
Weekly Report: what happened at ARNI last week (0825-0829)?
Weekly Report · 09/01 10:13
Weekly Report: what happened at ARNI last week (0818-0822)?
Weekly Report · 08/25 10:20
Weekly Report: what happened at ARNI last week (0811-0815)?
Weekly Report · 08/18 10:15
Weekly Report: what happened at ARNI last week (0804-0808)?
Weekly Report · 08/11 10:19
Weekly Report: what happened at ARNI last week (0728-0801)?
Weekly Report · 08/04 10:21
Weekly Report: what happened at ARNI last week (0721-0725)?
Weekly Report · 07/28 10:21
More
About ARNI
Arno Therapeutics, Inc. is an early-stage company focused on developing products for the treatment of cancer and other life threatening diseases. The Company's product development pipeline includes Onapristone, AR-42, and AR-12 and analogs. Onapristone is indicated for endometrial, prostate and breast cancer indications. AR-42 is provided for hematological malignancies and solid tumors indications. AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets. Onapristone is a type 1 anti-progestin hormone blocker that has considerable anti-tumor activity in patients with breast cancer. The Company is engaged in developing and commercializing AR-42, which is an oral cancer therapy in early clinical development. AR-42 is a spectrum deacetylase inhibitor of both histone and non-histone proteins, which has potency and activity in solid tumors and hematological malignancies. AR-12 is an orally available cancer treatment.

Webull offers Arno Therapeutics Inc stock information, including EXMKT: ARNI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARNI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARNI stock methods without spending real money on the virtual paper trading platform.